SCHEMBL17818674

SCHEMBL17818674

O=C(O)CC(C(=O)O)(C(=O)O)C(=O)O.[Ag]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
CYP2C19 P33261 2/20 0.48
HIF1A Q16665 2/20 0.48
TSHR P16473 2/20 0.48
CYP2D6 P10635 1/20 0.48
HMGCR P04035 1/20 0.43
CHRM1 P11229 1/20 0.43
TBXA2R P21731 1/20 0.43
ADRA1A P35348 1/20 0.43
ACLY P53396 3/20 0.40
CPT2 P23786 2/20 0.39
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
FFAR1 O14842 1/20 0.36
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
LMNA P02545 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23126 0.97 ALDH1A1 (0.53) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
SCHEMBL11436629 0.93 ALDH1A1 (0.50) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
SCHEMBL2548829 0.79 CYP2C19 (0.48) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
SCHEMBL28890751 0.77 ALDH1A1 (0.42) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
SCHEMBL2460883 0.75 ALDH1A1 (0.40) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
SCHEMBL7854011 0.73 ALDH1A1 (0.39) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
Citric Acid SCHEMBL306676 0.71 ALDH1A1 (0.94) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
Citric Acid SCHEMBL29740281 0.71 ALDH1A1 (0.94) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
Citric Acid SCHEMBL3692334 0.71 ALDH1A1 (0.94) ALDH1A1CYP2C19HIF1ATSHRCYP2D6
Citric Acid SCHEMBL33987 0.71 ALDH1A1 (0.94) ALDH1A1CYP2C19HIF1ATSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9683123-B2 Silver ink PESOLVE CO., LTD. (KR) 2017-06-20 US disclosed
US-20160168408-A1 SILVER INK PESOLVE CO., LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168408-A1 SILVER INK TP53, MKI67, NRAS ALDH1A1 23/4885CYP2C19 1013/4885HIF1A 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.